SEC Form 4 · accession 0000899243-16-020103
SOLENO THERAPEUTICS INC · SLNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bhatnagar Anish
Officer — President and CEO · Director
Period of report
May 13, 2016
Accepted (ET)
May 16, 2016 · 5:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001484565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 13, 2016 | P | 5,000 | $1.149 | A | 73,419 | D |
Table II — derivative securities
No Table II lines on this filing.